CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
US-12344657-B2 · Jul 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Highfill Steven patents
Highfill Steven is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Highfill Steven |
| Total patents | 6 |
| First publication | Apr 9, 2019 |
| Latest publication | Jul 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)-expressing cell
US-2023374105-A1 · Nov 23, 2023 · US
Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)- expressing cell
US-2022195010-A1 · Jun 23, 2022 · US
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
US-11149076-B2 · Oct 19, 2021 · US
Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)- expressing cell
US-2019292238-A1 · Sep 26, 2019 · US
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
US-10253086-B2 · Apr 9, 2019 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 6 |
| Univ Pennsylvania | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K16/2866 | 6 |
| C07K16/2803 | 6 |
| C07K2319/33 | 6 |
| C07K2319/03 | 6 |
| C07K2317/569 | 6 |